Product category:
Reagents and catalysts
News Release from: Randox Laboratories | Subject: Lipoprotein profiling
Edited by the Laboratorytalk Editorial
Team on 30 November 2007
Full lipoprotein profiling service
As the incidence of cardiovascular disease (CVD) is rising, it is becoming more and more important to assess risk factors for CVD, to reduce the incidence and mortality of the disease
As the incidence of cardiovascular disease (CVD) is rising, it is becoming more and more important to assess risk factors for CVD, to reduce the incidence and mortality of the disease Apolipoproteins are the main structural components of lipoproteins and have been linked to CVD risk
This article was originally published on Laboratorytalk on 12 Aug 2005 at 8.00am (UK)
Related stories
Biochip technology comes to the routine lab
Latest innovation in multi-analyte biochip array technology is described as the perfect candidate for profiling drugs of abuse or cytokine arrays
Randox can offer a full lipoprotein profile including HDL, LDL, small dense LDL and apolipoproteins for CVD risk assessment.
The apo B/ apo A-I ratio has been used as an indicator of CVD risk.
Apolipoprotein A I (apo A-1) is the main component of HDL (the 'good' cholesterol).
Apo A-I levels are inversely proportional to atherosclerosis.
Apo B is a component of LDL (the 'bad' cholesterol).
Increased levels of apo B indicate increased CVD risk, even when total and LDL cholesterol are within normal ranges.
This may be due to an increase in small dense LDL, which is up to four times more atherogenic than large buoyant LDL.
Apo A-I and B as well as other apolipoproteins and lipoproteins are available from Randox as simple, highly accurate immunoturbidimetric tests for fully automated analysers in the routine clinical lab. Request a free brochure from Randox Laboratories ...
• Randox Laboratories: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
